Isofol Medical AB (OSTO:ISOFOL) Cyclically Adjusted Book per Share: kr2.28 (As of Mar. 2026)


OSTO:ISOFOL Isofol Medical AB OSTO:ISOFOL
30 GF Score
Price kr0.81
! 2 Warning Signs
View Full Analysis

What is Isofol Medical AB Cyclically Adjusted Book per Share?

Isofol Medical AB OSTO:ISOFOL +5.88% 30 Cyclically Adjusted Book per Share is kr2.28 as of Mar. 2026. GuruFocus rates OSTO:ISOFOL with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Isofol Medical AB's adjusted book value per share for the three months ended in Mar. 2026 was kr0.330. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr2.28 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-05), Isofol Medical AB's current stock price is kr0.81. Isofol Medical AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr2.28. Isofol Medical AB's Cyclically Adjusted PB Ratio of today is 0.36.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Isofol Medical AB was 0.36. The lowest was 0.00. And the median was 0.00.


Isofol Medical AB  (OSTO:ISOFOL) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Isofol Medical AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.81/2.28
=0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Isofol Medical AB was 0.36. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Isofol Medical AB Cyclically Adjusted Book per Share Related Terms


Isofol Medical AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Isofol Medical AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Isofol Medical AB Cyclically Adjusted Book per Share Chart

Isofol Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 2.27

Isofol Medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 2.27 2.28

OSTO:ISOFOL vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Isofol Medical AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Isofol Medical AB Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Isofol Medical AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Isofol Medical AB's Cyclically Adjusted PB Ratio falls into.


OSTO:ISOFOL
30GF Score
Isofol Medical AB OSTO:ISOFOL
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Isofol Medical AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Isofol Medical AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.33/133.5600*133.5600
=0.330

Current CPI (Mar. 2026) = 133.5600.

Isofol Medical AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.000 101.019 0.000
201609 0.000 101.138 0.000
201612 0.170 102.022 0.223
201703 0.000 102.022 0.000
201706 6.133 102.752 7.972
201709 5.821 103.279 7.528
201712 5.417 103.793 6.971
201803 5.110 103.962 6.565
201806 4.847 104.875 6.173
201809 4.577 105.679 5.785
201812 4.126 105.912 5.203
201903 3.729 105.886 4.704
201906 3.188 106.742 3.989
201909 2.535 107.214 3.158
201912 1.633 107.766 2.024
202003 0.762 106.563 0.955
202006 1.260 107.498 1.565
202009 1.010 107.635 1.253
202012 0.555 108.296 0.684
202103 0.199 108.360 0.245
202106 2.344 108.928 2.874
202109 2.064 110.338 2.498
202112 1.731 112.486 2.055
202203 1.471 114.825 1.711
202206 1.177 118.384 1.328
202209 1.000 122.296 1.092
202212 0.862 126.365 0.911
202303 0.784 127.042 0.824
202306 0.743 129.407 0.767
202309 0.709 130.224 0.727
202312 0.661 131.912 0.669
202403 0.615 132.205 0.621
202406 0.554 132.716 0.558
202409 0.495 132.304 0.500
202412 0.424 132.987 0.426
202503 0.350 132.825 0.352
202506 0.270 133.699 0.270
202509 0.429 133.480 0.429
202512 0.384 133.390 0.384
202603 0.330 133.560 0.330

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr2.28 mean?
Isofol Medical AB (OSTO:ISOFOL) has a Cyclically Adjusted Book per Share of kr2.28 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Isofol Medical AB and its competitors.
Is Isofol Medical AB's Cyclically Adjusted Book per Share too high?
Isofol Medical AB's current Cyclically Adjusted Book per Share is kr2.28. Overall, Isofol Medical AB has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Isofol Medical AB's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Isofol Medical AB's Cyclically Adjusted Book per Share of kr2.28 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Isofol Medical AB and its competitors. Isofol Medical AB's current Cyclically Adjusted Book per Share is kr2.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Isofol Medical AB stock overvalued right now?
Isofol Medical AB (OSTO:ISOFOL) has a current Cyclically Adjusted Book per Share of kr2.28. The current Cyclically Adjusted Book per Share is kr2.28. Isofol Medical AB's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Isofol Medical AB (OSTO:ISOFOL), the current Cyclically Adjusted Book per Share is kr2.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Isofol Medical AB Business Description

Address Arvid Wallgrens Backe 20, Biotech Center, Gothenburg, SWE, SE-413 46
Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. Its products are used to increase efficacy and reduce the side effects of antimetabolite cancer treatment.
30GF Score

Get the complete analysis for OSTO:ISOFOL

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.81
Price